Article Versions Notes

Boccalini S, Gironi V, Buscemi P, Bonanni P, Muzii B, Parisi S, Borchiellini M, Bechini A. The Number Needed to Immunize (NNI) to Assess the Benefit of a Prophylaxis Intervention with Monoclonal Antibodies Against RSV. Vaccines. 2025; 13(8):791. https://doi.org/10.3390/vaccines13080791

Boccalini, Sara, Veronica Gironi, Primo Buscemi, Paolo Bonanni, Barbara Muzii, Salvatore Parisi, Marta Borchiellini, and Angela Bechini. 2025. "The Number Needed to Immunize (NNI) to Assess the Benefit of a Prophylaxis Intervention with Monoclonal Antibodies Against RSV" Vaccines 13, no. 8: 791. https://doi.org/10.3390/vaccines13080791

Boccalini, S., Gironi, V., Buscemi, P., Bonanni, P., Muzii, B., Parisi, S., Borchiellini, M., & Bechini, A. (2025). The Number Needed to Immunize (NNI) to Assess the Benefit of a Prophylaxis Intervention with Monoclonal Antibodies Against RSV. Vaccines, 13(8), 791. https://doi.org/10.3390/vaccines13080791